Roivant Sciences Ltd (NASDAQ:ROIV) price is hovering lower on Wednesday, April 17, dropping -0.45% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $10.71. The company’s P/E ratio in the trailing 12-month period read 2.05. Taking into account the 52-week price action we note that the stock hit a 52-week high of $13.24 and 52-week low of $7.60. The stock added 8.02% on its value in the past month.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ROIV a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as Hold.
The overview shows that ROIV’s price is at present -1.18% off the SMA20 and -2.44% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 45.43, with weekly volatility standing at 2.39%. The indicator jumps to 3.69% when calculated based on the past 30 days. Roivant Sciences Ltd (NASDAQ:ROIV)’s beta value is holding at 1.31, while the average true range (ATR) indicator is currently reading 0.40.
An analysis of the Roivant Sciences Ltd (NASDAQ:ROIV) stock in terms of its daily trading volume indicates that the 3-month average is 7.41 million.
Current records show that the company has 760.14M in outstanding shares. The insiders’ percentage holdings are 31.39% of outstanding shares while the percentage share held by institutions stands at 50.49%. But the -5.06% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
